These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 22931448)

  • 1. Nanobiotechnology-based strategies for crossing the blood-brain barrier.
    Jain KK
    Nanomedicine (Lond); 2012 Aug; 7(8):1225-33. PubMed ID: 22931448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK
    Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA
    Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
    Meng J; Agrahari V; Youm I
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier delivery.
    Pardridge WM
    Drug Discov Today; 2007 Jan; 12(1-2):54-61. PubMed ID: 17198973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern methods for delivery of drugs across the blood-brain barrier.
    Chen Y; Liu L
    Adv Drug Deliv Rev; 2012 May; 64(7):640-65. PubMed ID: 22154620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
    Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
    Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of drugs to the brain via the blood brain barrier using colloidal carriers.
    Tucker IG; Yang L; Mujoo H
    J Microencapsul; 2012; 29(5):475-86. PubMed ID: 22563886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
    Gan CW; Feng SS
    Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
    Gaillard PJ; de Boer AG
    Methods Mol Biol; 2008; 437():161-75. PubMed ID: 18369968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review.
    Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP
    Curr Pharm Biotechnol; 2020; 21(5):374-383. PubMed ID: 31793421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle technology for drug delivery across the blood-brain barrier.
    Lockman PR; Mumper RJ; Khan MA; Allen DD
    Drug Dev Ind Pharm; 2002 Jan; 28(1):1-13. PubMed ID: 11858519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to improve drug delivery across the blood-brain barrier.
    de Boer AG; Gaillard PJ
    Clin Pharmacokinet; 2007; 46(7):553-76. PubMed ID: 17596102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of drugs across the blood-brain barrier by nanoparticles.
    Wohlfart S; Gelperina S; Kreuter J
    J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.